We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Maxcyte Inc | LSE:MXCT | London | Ordinary Share | COM STK USD0.01 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | |
---|---|---|---|---|---|
-2.50 | -0.72% | 342.50 | 335.00 | 350.00 |
High Price | Low Price | Open Price | Shares Traded | Last Trade |
---|---|---|---|---|
345.00 | 342.50 | 345.00 | 24,274 | 16:17:54 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 44.26M | -23.57M | -0.2277 | -18.75 | 441.96M |
Date | Time | Source | Headline |
---|---|---|---|
20/3/2024 | 10:16 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing |
20/3/2024 | 10:05 | UK RNS | MaxCyte, Inc. Grant of Options, RSUs and PSUs and PDMR Dealing |
13/3/2024 | 11:54 | ALNC | IN BRIEF: MaxCyte loss widens in 2023 as core revenue declines 25% |
13/3/2024 | 07:05 | UK RNS | MaxCyte, Inc. Filing of form 10-K for FY ended December 31, 2023 |
13/3/2024 | 07:00 | UK RNS | MaxCyte, Inc. Reports Q4 & FY 2023 Financial Results |
12/3/2024 | 20:05 | UKREG | MaxCyte Reports Fourth Quarter and Full Year 2023 Financial Results and.. |
06/3/2024 | 08:58 | UK RNS | MaxCyte, Inc. TR-1: Notification of major holdings |
05/3/2024 | 20:43 | ALNC | EARNINGS: dotdigital eyes rosy future; Beeks Financial turns to profit |
05/3/2024 | 07:00 | UK RNS | MaxCyte, Inc. Preliminary FY Results & 2024 Guidance |
04/3/2024 | 21:05 | UKREG | MaxCyte Initiates Full Year 2024 Guidance and Reaffirms 2023 Preliminary.. |
1 Year Maxcyte Chart |
Intraday Maxcyte Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions